Jundishapur Journal of Microbiology

Published by: Kowsar

Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer

Seyed Jalal Kiani 1 , Somayeh Shatizadeh Malekshahi 1 , Zohreh Yousefi Ghalejoogh 1 , Nastaran Ghavvami 1 , Nazanin Zahra Shafiei Jandaghi 1 , Reza Shahsiah 2 , Isa Jahanzad 2 and Jila Yavarian 1 , *
Authors Information
1 Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2 Pathology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2015, 8 (12); e26441
  • Published Online: December 26, 2015
  • Article Type: Research Article
  • Received: April 13, 2015
  • Accepted: June 6, 2015
  • DOI: 10.5812/jjm.26441

To Cite: Jalal Kiani S, Shatizadeh Malekshahi S, Yousefi Ghalejoogh Z, Ghavvami N, Shafiei Jandaghi N Z, et al. Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer, Jundishapur J Microbiol. 2015 ; 8(12):e26441. doi: 10.5812/jjm.26441.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008; 17(7): 1611-22[DOI][PubMed]
  • 2. Reshmi G, Pillai MR. Beyond HPV: Oncomirs as new players in cervical cancer. FEBS Lett. 2008; 582(30): 4113-6[DOI][PubMed]
  • 3. Fabiano V, Mariani L, Giovagnoli MR, Raffa S, Vincenzoni C, de Michetti F, et al. Cervical cancer screening program based on HPV testing and conventional Papanicolaou cytology for jail inmates. Health. 2010; 2(9): 1027-32[DOI]
  • 4. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health. 2008; 43(4 Suppl)-25[DOI][PubMed]
  • 5. Lepique AP, Rabachini T, Villa LL. HPV vaccination: The beginning of the end of cervical cancer? - A Review. Mem Inst Oswaldo Cruz. 2009; 104(1): 1-10[PubMed]
  • 6. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008; 110(3 Suppl 2)-7[DOI][PubMed]
  • 7. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995; 172(3): 946-54[PubMed]
  • 8. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet. 1995; 345(8964): 1533-6[PubMed]
  • 9. Sarraf Z, Hamedi B, Hooshmand S, Mosalaie A, Robati M, Momtahan M, et al. The effect of extrafascial hysterectomy after completion of external beam radiotherapy for treatment of locally advanced stages (IIB-III) of Cervical Cancer. Iran Red Crescent Med J. 2013; 15(12)[DOI][PubMed]
  • 10. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996; 34(3): 745-7[PubMed]
  • 11. van den Brule AJ, Claas EC, du Maine M, Melchers WJ, Helmerhorst T, Quint WG, et al. Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol. 1989; 29(1): 20-7[PubMed]
  • 12. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998; 36(10): 3020-7[PubMed]
  • 13. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994; 169(2): 235-40[PubMed]
  • 14. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997; 35(3): 791-5[PubMed]
  • 15. Sasagawa T, Minemoto Y, Basha W, Yamazaki H, Nakamura M, Yoshimoto H, et al. A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res. 2000; 67(2): 127-39[PubMed]
  • 16. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004; 42(7): 3176-84[DOI][PubMed]
  • 17. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006; 24 Suppl 3-10[DOI][PubMed]
  • 18. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007; 370(9590): 890-907[DOI][PubMed]
  • 19. Romero-Pastrana F. Detection and typing of human papilloma virus by multiplex PCR with type-specific primers. ISRN Microbiol. 2012; 2012: 186915[DOI][PubMed]
  • 20. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995; 87(11): 796-802[PubMed]
  • 21. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1): 12-9[DOI][PubMed]
  • 22. World Health Organisation . Human Papillomavirus and Related Diseases Report.
  • 23. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, Rashidi BH, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol. 2013; 128(2): 277-81[DOI][PubMed]
  • 24. Shahsiah R, Khademalhosseini M, Mehrdad N, Ramezani F, Nadji SA. Human papillomavirus genotypes in Iranian patients with cervical cancer. Pathol Res Pract. 2011; 207(12): 754-7[DOI][PubMed]
  • 25. Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination. J Med Virol. 2015; 87(2): 287-95[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments